Susquehanna International »

Liminatus Pharma shares owned by Susquehanna International

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by Susquehanna International

Quarter filed Position value Share count Share price at filing
2025-12-31 $836 24k 0.04

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Meta Platforms Cl A (META)
Apple (AAPL)
Spdr Gold Tr Gold Shs (GLD)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
Broadcom (AVGO)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for Susquehanna International

Top funds holding Liminatus Pharma

Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital
Toronto-Dominion Bank
LMR Partners
Gts Securities

View all funds holding Liminatus Pharma